An emotion regulation strategy known as cognitive reappraisal helped reduce the typically heightened and habitual attention to drug-related cues and contexts in cocaine-addicted individuals, a study by Mount Sinai researchers has found.
Category: From Newswise – Substance Abuse
Why is it so hard to withdraw from some antidepressants?
Researchers at the University of Illinois Chicago are a step closer to discovering why it is so difficult for people to withdraw from some antidepressant medications. The paper “Antidepressants produce persistent Gαs associated signaling changes in lipid rafts following drug withdrawal,” published in the journal Molecular Pharmacology, addresses the molecular and cellular mechanisms that cause antidepressant withdrawal syndrome.
AANA Joins Bipartisan Congressional Movement to Expand Use of Non-Opioid Pain Management
o help increase access to the availability of non-opioid pain management treatments, the American Association of Nurse Anesthetists (AANA) supports the recent introduction of the Non-Opioids Prevent Addiction in the Nation (NOPAIN) Act introduced by U.S. Rep. Terri Sewell (D-AL), along with Reps. David McKinley (R-WV), Ann Kuster (D-NH), and Brian Fitzpatrick (R-PA). The Senate version of this legislation (S. 589) was previously introduced.
Older Adults with Functional Impairments Linked to Prescription Drug Use/Misuse
Researchers at University of California San Diego School of Medicine found that functional impairments among adults aged 50 and older are associated with a higher risk of medical cannabis use; and prescription opioid and tranquilizer/sedative use and misuse.
New study of how US recreational cannabis legalization could change illegal drug markets
A study published in the scientific journal Addiction provides the most comprehensive evidence to date of the association between recreational cannabis laws (RCLs) in US states and responses in the illegal markets for cannabis, heroin, and other drugs in those states.
Access to overdose-reversing drugs declined during pandemic, researchers find
In a new study, clinician-researchers at Beth Israel Deaconess Medical Center (BIDMC) analyzed naloxone prescription trends during the COVID-19 pandemic in the United States and compared them to trends in opioid prescriptions and to overall prescriptions.
Partners May Influence Pregnant Women’s Alcohol Use and Risk Factors for Infant Development
The partners of mothers-to-be can influence the women’s drinking and depression during pregnancy, affecting their babies’ development, a new study suggests. The findings highlight the importance of partners’ role in reducing risk for expectant mothers. Pregnant women’s behavioral health is known to be influenced by their relationships with their partners. Partners’ higher substance use, and women’s lower relationship satisfaction, are associated with higher maternal substance use. Women who feel supported by their partners, in contrast, report less prenatal anxiety and depression and lower postpartum distress. Drinking and depression during pregnancy are each associated with multiple health problems, such as premature birth and delayed infant development. The study in Alcoholism: Clinical & Experimental Research explores the role of partners, prenatal alcohol use, and infant outcomes together, aiming for a more comprehensive understanding of how these factors combine.
‘Opioid treatment deserts’ abound, study finds
Neighborhoods without opioid treatment providers likely serve as a widespread barrier to care for those who are ready to seek help, a new study has found. Nearby access, including by public transit, is essential to treatment success, researchers say.
Model Pinpoints Predictive Factors for Long-Term Opioid Use
Researchers have developed a statistical model to predict the use of long-term opioids after total joint replacement.
Researchers Find Link Between ABCB1 Gene and Long-Term Opioid Use
In a study of hundreds of patients undergoing total knee or hip replacement, researchers identified a gene called ABCB1 that may predict long-term pain and opioid use.